InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Weissman James B, 首席运营官. Officer active across 2 companies, notably Dicerna Pharmaceuticals Inc. Aggregated, 4 filings have been recorded. History available since 6 July 2021. The latest transaction was disclosed on 24 July 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Weissman James B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
8,390 股0Common StockSEC:0000950170-24-086881:0
18,100 股@ US$38.2572.6% 占其流量Common StockSEC:0001399529-21-000205:0
3,775 股Common StockSEC:0001399529-21-000175:0
30,000 股@ US$9.0927.4% 占其流量Common StockSEC:0001399529-21-000132:0
4 条申报中的 4 条
About Weissman James B
James B. Weissman is the Chief Operating Officer and Executive Vice President at Dicerna Pharmaceuticals Inc. He oversees the company's operations and is responsible for implementing operational strategies. With significant experience in the biopharmaceutical sector, he plays a key role in Dicerna's growth and innovation. His leadership is essential in achieving the company's objectives.
